This video is sponsored by the Duke Clinical Medical Series.
Topics include:
* Risk Stratification in the Care of ACS: The Role of the ED in Matching Treatment to
Risk in Cardiac Care
* Serum Markers of AMI: Myoglobin
* TIMI Risk Score (NSTE-ACS)
* Level 2 (High-risk) ACS Clinical Features:
* ACS Diagnostic Flow Summary
The moderator, Kristin Newby, MD, has indicated that she receives research/grant support
from Bristol-Myers Squibb, Sanofi, Millennium Pharmaceuticals, Inc., Schering-Plough
Research Institute, Novartis and Roche Diagnostics Corporation. Dr. Newby is also a member
of an advisory board for Eli Lilly and a consultant for Proctor and Gamble; she has spoken
at scientific symposia for Aventis, Bristol-Myers Squibb, Sanofi and Millennium
Pharmaceuticals, Inc.
The guest faculty, James Hoekstra, MD, has indicated that he is an honorarium recipient of
Schering Plough, The sanofi-aventis Group, Bristol-Myers Squibb, and the Medicine's
Company.
|
|